RXO
Overvalued by 67.4% based on the discounted cash flow analysis.
Market cap | $4.29 Billion |
---|---|
Enterprise Value | $4.29 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.03 |
Beta | 1.12 |
Outstanding Shares | 117,579,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -152.35 |
---|---|
PEG | 201.25 |
Price to Sales | 0.69 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 1.52 |
Enterprise Value to EBIT | -18198.9 |
Enterprise Value to Net Income | -213 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.41 |
No data
No data